Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Social Media in the Pharmaceutical Industry

23 Jan 2013 - 24 Jan 2013 - London, UK



Bookmark and Share


Connectivity, Engagement and Implementation

Sponsored by: greater than one

Book by 28th September and receive a £300 discount

Visit www.social-media-pharma.com to claim your discount!

SMi Group is proud to present the 5th conference in their highly successful series of Social Media in the Pharmaceutical Industry this January that will allow companies to focus on how to improve their existing social media strategies, how to innovate into the new and emerging techniques and technologies and enhancing their company’s engagement potential. We are excited to also feature talks from key companies in the industry, including Google, Pfizer, UCB Pharma and Bayer, and will focus on case studies from the industry, techniques for social media use and implementation of social media mechanisms. 

Key reasons to attend include:

Speak with the key opinion leaders of the industry about the future of social media, digital pharma, e-marketing and regulations

Hear about the case studies in the industry: how the affected those involved, how they were successful and the reasons that they were unsuccessful

Learn about crisis management, adaptations and risk management in unsuccessful campaigns, and apply them to your own company’s

Discuss the latest technologies in social media with companies that create them, and debate their benefits and difficulties with those companies that utilise them

Put forward problems and difficulties of your own, and discuss potential solutions and action plans for the future

Expert Key speakers include:

Beat Buehlmann, Industry Leader Healthcare UK, Google Inc

Trish Nettleship, Director, Social Media & Influence, UCB Pharma

 • Rahul Agrawal, Global Director, Clinical Development and Strategic 

Marketing, Bayer Healthcare

Andrew Widger, Director, Media Relations EMEA Pfizer Inc

Josep Picas, President, European Association of Healthcare IT Managers


Contact Fateja Begum on tel +44 0 207 827 6184 or email fbegum@si-online.co.uk 





Further information
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!